Clinical Trial: A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676006) titled 'A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia' on June 22.

Brief Summary: This is a single-arm, open-label, dose-escalation, prospective exploratory clinical study intended to evaluate the safety, efficacy and cellular pharmacokinetics of GT737 cells in adult patients with relapsed/refractory acute myeloid leukemia (AML).

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Relapsed/Refractory Acute Myeloid Leukemia (AML)

Intervention: BIOLOGICAL: GT737 Injection

GT737 Injection

Recru...